Foresite Capital Management Iii, LLC Wave Life Sciences Ltd. Transaction History

Foresite Capital Management Iii, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$19.17 - $27.4 $2.68 Million - $3.83 Million	-139,900 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$22.93 - $42.84 $573,250 - $1.07 Million	-25,000 Reduced 15.16%	139,900 $3.65 Million
Q1 2019 May 14, 2019	BUY	$32.69 - $47.91 $3.76 Million - $5.5 Million	114,900 Added 229.8%	164,900 $6.41 Million
Q3 2018 Nov 13, 2018	SELL	$36.35 - $55.2 $908,750 - $1.38 Million	-25,000 Reduced 33.33%	50,000 $2.5 Million
Q1 2018 May 15, 2018	SELL	$32.45 - $54.7 $2.83 Million - $4.78 Million	-87,347 Reduced 53.8%	75,000 $3.01 Million
Q4 2017 Feb 13, 2018	SELL	$21.8 - $39.35 $15.3 Million - $27.6 Million	-700,980 Reduced 81.2%	162,347 $5.7 Million
Q3 2017 Nov 13, 2017	SELL	$16.4 - $25.05 $2.31 Million - $3.53 Million	-140,773 Reduced 14.02%	863,327 $18.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,004,100	1,004,100 $18.7 Million

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.29B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.